This Article Full Text Full Text (PDF) All Versions of this Article: 37/8/2066    most recent 01.STR.0000229899.66019.62v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Legge, S. D. Articles by Hachinski, V. Search for Related Content PubMed PubMed Citation Articles by Legge, S. D. Articles by Hachinski, V. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information CT Scans Stroke Related Collections Acute Cerebral Infarction Acute Stroke Syndromes Thrombolysis

(Stroke. 2006;37:2066.)
© 2006 American Heart Association, Inc.

Original Contributions

Neglecting the Difference

Does Right or Left Matter in Stroke Outcome After Thrombolysis?

Silvia Di Legge, MD, PhD; Gustavo Saposnik, MD, MSc; Yongchai Nilanont, MD Vladimir Hachinski, MD, DSc, FRCPC

From the Stroke Unit (S.D.L.), Stroke Unit, Università di Tor Vergata, Rome, Italy; the Department of Clinical Neurological Sciences (G.S., V.H.), London Health Science Centre, University of Western Ontario, London, Ontario, Canada; the Division of Neurology (Y.N.), Siriraj Hospital, Mahidol University Bangkok, Thailand; and the Stroke Research Program (G.S.), Department of Medicine, St. Michael’s Hospital, University of Toronto, Ontario, Canada.

Correspondence to Silvia Di Legge, MD, PhD, Stroke Unit, University of Tor Vergata, Viale Oxford 81-00133 Rome, Italy. E-mail silvia.dilegge{at}uniroma1.it

Background and Purpose— Patients with right hemispheric strokes (RHSs) present later to an emergency department, have a lower chance to receive intravenous recombinant tissue plasminogen activator (IV rt-PA), and have worse clinical outcomes than do patients with left hemispheric strokes (LHSs). We analyzed outcomes after IV rt-PA with respect to the side of the affected hemisphere.

Methods— A prospective cohort of acute stroke patients was treated with IV rt-PA at the London Health Sciences Centre (December 1998 to March 2003). Differences between patients with RHS and LHS were identified by univariate analysis. Logistic-regression analysis was used to determine a subset of variables independently associated with major neurological improvement at 24 hours and good outcome at 3 months after treatment.

Results— Of 219 stroke patients who received IV rt-PA, 165 had hemispheric strokes (68 RHSs and 97 LHSs). Patients with RHSs were less hypertensive (P=0.001) and had lower pretreatment National Institutes of Health Stroke Scale (NIHSS) scores (P=0.005). LHS (odds ratio [OR], 2.29; 95% CI, 1.14 to 4.59; P=0.019), age (OR, 0.96; 95% CI, 0.93 to 0.99; P=0.012), and pretreatment NIHSS (OR, 0.83; 95% CI, 0.78 to 0.89; P<0.0001) were independent predictors of 3-month outcome. Female sex (OR, 3; 95% CI, 1.53 to 5.90; P=0.001) and LHS (OR, 2.07; 95% CI, 1.05 to 4.08; P=0.03) were independent predictors of major neurological improvement at 24 hours after IV rt-PA.

Conclusions— Despite higher pretreatment NIHSS, patients with LHSs have a 2-fold increased chance of a good outcome 3 months after rt-PA treatment compared with patients with RHSs. This gain can be clinically detected at 24 hours after treatment. These results need to be coupled with neuroimaging and hemodynamic characteristics known to influence stroke outcome.

Key Words: acute stroke • outcome • thrombolysis

This article has been cited by other articles:

				E. Meseguer, M. Mazighi, J. Labreuche, C. Arnaiz, L. Cabrejo, T. Slaoui, C. Guidoux, J.-M. Olivot, H. Abboud, B. Lapergue, et al. Outcomes of Intravenous Recombinant Tissue Plasminogen Activator Therapy According to Gender: A Clinical Registry Study and Systematic Review Stroke, June 1, 2009; 40(6): 2104 - 2110. [Abstract] [Full Text] [PDF]